topdoctors logo
Doctors and clinicsSpecialtiesConditionsDentists

Login
Area for professionals
  • Home
  • Doctors
  • Clinical Oncology
  • Clinical Oncologists in Central London
  • Dr Paula Wells

Dr Paula Wells

Clinical oncology in Central London

MBBS MRCP FRCR PhD
GMC: 3120550
Book
Expert in:
Prostate cancer
Chemotherapy
Brachytherapy
Brachytherapy for prostate cancer
Stereotactic radiotherapy
CyberKnife
  • Information
  • CV
  • Content
  • Reviews
  • Treatments

Clinics

Leaders in Oncology Care (LOC) - part of HCA Healthcare
  • Leaders in Oncology Care (LOC) - part of HCA Healthcare profile image

    Leaders in Oncology Care (LOC) - part of HCA Healthcare

    95-97 Harley Street LOC, Leaders in Oncology Care, Central London, W1G 6AF

Credentials

Professional experience

  • 40 years of experience
  • Consultant Clinical Oncologist, Leaders in Oncology Care (2007 - present)
  • Consultant Clinical Oncologist, St Bartholomews Hospital (2000 - present)
View more

Subspecialties

  • Prostate brachytherapy
  • Stereotactic radiotherapy - Cyberknife®
  • Chemo-radiotherapy
  • Immunotherapy
View more

Professional memberships

  • Royal College of Radiologists
  • Royal College of Physicians

Education

  • CRC Clinical Fellowship, The Institute of Cancer Research, The University of London (2000)
  • PhD in Positron Emission Tomography, Imperial College London (1997)
  • FRCR Clinical Oncology Core Training, Royal College of Radiologists (1994)
  • MRCP, Royal College of Physicians (1989)
  • MBBS, St Bartholomews Hospital Medical School (1986)
View more

Teaching posts

  • Royal College of Radiologists College Tutor St Bartholomews Hospital
  • Clincial and Educational Supervisor - Core Medical and Specialist Clincial Oncology Trainees
  • Member of Specialist Training Committee - Clinical Oncology
  • Trainee Programme Management Committee (Clinical Oncology) - UCL Partners
View more

Positions in organisations

  • Principal Investigator, North East London Cancer Network

Publications and conferences

  • Treatment of insomnia with Ritanserin. Lancet 1990 vol 336 p3799
  • Autologous bone marrow transplantation in multiple myeloma. A single centre experience of 23 patients. Leukaemia and lymphoma 1994 vol 15 p273-279
  • Wells P, Wotherspoon A, Burnet NG, Tobias JS.. Cutaneous B cell lymphoma with subsequent laryngeal involvement. Clinical Oncology 1995 vol 7 no 1, p62-64
  • The effect of radiotherapy on urethral obstruction from carcinoma of prostate. British Journal of Urology 1996 vol 78 p752-755
  • The potential of tracer kinetic studies in drug development programs: A new investigational area of cancer research. Drug Information Journal 1997; 31 (3) 1045-1049
  • Pharmacokinetic assessment of new anti-cancer drugs using spectral analysis and positron emission tomography. Cancer Chemotherapy and Pharmacology 1998 42: 183-192
  • Monitoring response to treatment in the development of anti-cancer drugs using positron emission tomography (PET) Drug Information Journal 1999 33:1 237-244
  • A general method to correct PET data for tissue metabolites using a dual-scan approach. Journal of Nuclear Medicine 2000 Apr; 41 (4): 706-11
  • On-line measurement of exhaled [11C)CO2 during PET Journal of Nuclear Medicine 2000 Apr; 41 (4); 605-11
  • Assessment of proliferation In vivo using 2-11C thymidine positron emission tomography in advanced intra-abdominal malignancies. Cancer Research 2002 62: 5698-5702
  • Thymidine Positron Emission Tomography as an indicator of Thymidylate Synthase Inhibition in patients treated with AG337 JNCI 2003 95 (9):675-682.
  • Measurement of renal tumour and normal tissue perfusion using Positron Emission Tomography in a Phase II Clinical Trial of Razoxane. British Journal of Cancer 2003 89, 262-267.
  • Assessment of inter- and intra-patient variability in C1502 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers. Clinical Cancer Research 2003 15; 9 (17): 6350-6.
  • Measuring tumour pharmacodynamic response using PET proliferation probes: the case for 2-[(11)C]-thymidine. Biochem Biophys Acta 2004 17;1705 (2):91-102.
  • Sentinel Node Biopsy in the management of primary Cutaneous Melanoma. British Journal Dermatology 2005 152 91):176.
  • Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast. Clinical Oncology. 2005 feb;17(1):32-8
  • Thymidine positron emission tomography reproducibility in humans. Clinical Cancer Research. 2005 jun15;11 (12):4341-7.
  • Volume definition in radiotherapy planning for lung cancer – how the radiologist can help? Cancer Imaging 2006 sep 7;6:116-23.
  • Efficacy and safety of first or second-line Irinotecan, Cisplatin and Mitomycin in Mesothelioma. Cancer 2007 jan1; 109(1):93-9.
  • Phase 2 trial of Irinotecan, Cisplatin and Mitomycin for relapsed small cell lung cancer. Int J Cancer 2007 Dec 1; 121(11):2575-7.
  • Aggressive epidermotropic cutaneous CD8+ (Berti's) lymphoma. Clin Exp Dermatol. 2010 Jun;35(4):e210-2.
  • Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy? Br J Radiol. 2014 May;87(1037):20130696.
  • Skeletal Health Part 1: Overview Of Bone Health and Management In the Cancer Setting. Urol Nurs. 2016 Jan-Feb;36(1):17-21, 26. Review.
  • Skeletal Health Part 2: Development of a Nurse Practitioner Bone Support Clinic for Urologic Patients. Urol Nurs. 2016 Jan-Feb;36(1):22-6
  • Retrospective Audit: Does Prior Assessment by Oral and Maxillofacial Surgeons Reduce the Risk of Osteonecrosis of The Jaw in Patients Receiving Bone-Targeted Therapies for Metastatic Cancers to the Skeleton?--Part II. Urol Nurs. 2016 May-Jun;36(3):117-22, 132.
  • Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Urol Nurs. 2016 May-Jun;36(3):111-6, 154. Review.
  • IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1367-77.
  • Positron emission tomography: A new investigational area for cancer research Clinical Oncology 1996 8: 7-14
  • Bladder cancer Chapte In: Treatment of cancer, 4th edition 2002. Edited by: Price P & Sikora K
  • Chapter in: Cancer in Primary Care Edited Gore M and Russell D 2003
  • Chapter in: Cancer in Primary Care Edited Gore M and Russell D 2003
View more

Prizes and awards

  • Cancer Research Campaign Clinical Research Fellowship 2000
  • American Society Clinical Oncology Merit Award 1997
  • Winner of Royal College of Radiologists National Competition for Glaxo Wellcome Fellowship 1996
  • European Society for Therapeutic Radiation Oncology Travel Award 1996
  • British Oncological Association Young Investigator Award 1996
  • Rohan Williams Medal Clinical Oncology 1994
View more

Languages spoken

  • English
Registration number: 3120550
The doctor, or where applicable the hospital or medical centre in which the doctor provides services, undertakes to keep the information relating to the prices of services published on their profile on the Top Doctors platform up to date at all times, ensuring that such prices correspond to those effectively charged to patients. In the event of any discrepancy between the published price and the price ultimately charged to the patient, the doctor and/or the relevant hospital or medical centre shall be solely liable towards the patient and towards Top Doctors for any claim or financial difference arising therefrom.

Request now: The appointment management service is free

Appointment subject to confirmation

Leaders in Oncology Care (LOC) - part of HCA Healthcare95-97 Harley Street LOC, Leaders in Oncology Care, Central London, W1G 6AF
Payment methodSelf-paying
  • About us
  • About Top Doctors
  • Why choose us?
  • Quality commitment
  • Selection process
  • Medical Specialist Advisory Panel
  • Privacy policy
  • Terms of Use
  • Cookies policy
  • Policy on the use of third party applications
  • Quality and Environmental Policy
  • Carbon reduction plan
  • Collaborate with us
  • Doctors
  • Our Clinics
  • Strategic alliances
  • Join us
  • Top Doctors Awards
  • Nominate doctors
  • Customer services
  • Doctors by medical insurance
  • Contact us
  • FAQs
  • All medical procedures
  • Press and media
  • Press
  • Medical articles

Contact
  • Doctors
  • Member
  • Patients
Social networks
CertificatesComodo Secure
Privacy policy and Terms of Use

Top Doctors | 20-22 Wenlock Road, London, England, N1 7GU